A nurse and midwife who resold mislabelled intravenous (IV) drips for profit has been struck off.
Nadia Mohammed’s conduct “brought the professions into disrepute”, according to a panel which investigated her IV treatment supply business called Ivitalise.
The panel rejected a claim from Ms Mohammed that her business dealings should not reflect on her “honest, reflective and consistently professional” work as a midwife in Leeds.
Earlier this month, a hearing of the Nursing and Midwifery Council Fitness to Practise Committee heard how Ms Mohammed was, with her husband, a director of Ivitalise, which had a contract to supply an IV drip product to another firm called White Night London Ltd.
After the contract came to an end in 2022, White Night became suspicious of the labels on the product and went direct to the manufacturer, Intravita, according to the panel’s judgment, published on Thursday.
Intravita confirmed that it did not recognise the label of the list of ingredients as one of their products.
The Nursing and Midwifery Council | cottonbro studio
According to the judgment, the allegation was that: “The ingredients listed on the bottle were incorrect and included Hydroxocobalamin which is a prescription only medicine, not used in any product by Intravita.
“The label also listed amino acids which are high risk products and, if used without preparatory health checks, could potentially cause serious health problems.”
The panel heard that the only product supplied by Intravita to Ivitalise does not contain either ingredient and is labelled “not for resale”.
The committee heard that Intravita sold bottles of the product to Ivitalise for £40, and these were relabelled and sold to White Night for £87.15.
The judgment said the allegation was that: “The label placed on the product and sold to White Night by Ivitalise appeared to be a more expensive product because of the different ingredients listed on the label which held a higher monetary value.”
Ms Mohammed admitted selling products to White Night without the permission of the manufacturer, between 2019 and 2022.
She also admitted labelling vials with false lot numbers and expiry dates.
But Ms Mohammed denied displaying a list of ingredients which did not reflect the true contents, displaying the Intravita name without their permission, and that this was carried out with the intention of making the product appear to be of a higher value.
She also denied her actions were dishonest.
But all the charges she denied were found proven earlier this week.
The judgment said: “The panel found that your conduct brought the professions into disrepute.
“Members of the public would not expect a registered nurse, midwife or independent nurse prescriber to act in this way.
“Your conduct undermined the trust and confidence that patients, colleagues and the public are entitled to place in registered professionals, particularly where honesty, integrity and patient safety are central to the role.”
It said: “The panel considered that there was a clear dissonance between the account of your conduct within midwifery practice and your conduct within Ivitalise.
“It rejected any suggestion that professionalism applied only in a hospital or clinical employment setting.
“The panel considered that the standards of honesty, integrity, openness, patient safety and accountability applied across all areas of your professional life.”
The panel heard how Ms Mohammed worked as a midwife in Leeds but now lives in Dubai.
She registered as a nurse in 2012, a midwife in 2015 and an independent nurse prescriber in 2018.
